跳至主要内容
临床试验/IRCT20171129037673N1
IRCT20171129037673N1已完成2 期

The Effect of oxytocin on clinical signs, ACTH & cortisol levels and methamphetamine craving in matrix maintenance treatment

Kashan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
Male

入选标准

  • 18-65 years old
  • Methamphetamine dependency as assessed by the substance abuse section of the Structured Clinical Interview of DSM-IV
  • Being at the Matrix Model of treatment.
  • Seeking treatment for methamphetamine use
  • Patients willing to participate in the intervention

排除标准

  • Suicide attempts within the past 12 months; suicidal ideas or psychotic symptoms in the past 6 months determined by a study team physician
  • Current opioid, alcohol or sedative physical dependence or cocaine dependence
  • Major cardiovascular disorder
  • Abnormal liver function
  • Having severe psychotic disorders
  • Metabolic diseases such as diabetes
  • Neurological diseases
  • Positive urine tests indicating abuse of any substance or stimulant
  • Unwillingness to participate in the study

研究者

相似试验